Study highlights difficulty of stopping antidepressants

AP Health

FILE- In this July 10, 2018 file photo, bottles of medications ride on a belt at a mail-in pharmacy warehouse in Florence, N.J. According to a study published Wednesday, Sept. 29, 2021 in the New England Journal of Medicine, British patients with a long history of depression highlights how difficult it can be to stop medication, even for those who feel well enough to try. (AP Photo/Julio Cortez, File)

A study of British patients with a long history of depression highlights how difficult it can be to stop medication, even for those who feel well enough to try.

Slightly more than half the participants who gradually discontinued their antidepressants relapsed within a year. By contrast, the relapse rate was lower — almost 40% — for those who remained on their usual medication during the study.

Both groups had been taking daily doses of common antidepressants, had recovered from their most recent bout of depression and felt healthy enough to consider stopping the drugs.

Previous research has also shown relapse is common, and an editorial published with the studyWednesday in the New England Journal of Medicine suggests medication for life may be advised for some patients with several previous bouts.

Counseling and behavior therapy are other options for patients who want to stop antidepressants, and studies show those treatments combined with medication work well for many.

Few of the British patients in the government-funded study were receiving any kind of psychological treatment. Though the United Kingdom’s national health system offers it, it is difficult to access because of long waiting times for treatment, said Gemma Lewis, the study’s lead author and a researcher at University College London. Patients in the study were being treated for depression by primary care doctors, which is common in the U.K., Lewis said.

Depression is a mood disorder that can include persistent, debilitating feelings of sadness, hopelessness and loss of interest in usual activities. It affects about 5% of adults worldwide, according to the World Health Organization. Reported rates are slightly lower in the U.K. and higher in the U.S. but Lewis said differing ways that depression is assessed makes comparisons between countries difficult.

The study enrolled 478 patients in four cities in England, most of them middle-aged white women. All were taking a common class of antidepressants called selective serotonin reuptake inhibitors, which include drugs known by the brand names Prozac and Zoloft. Half were randomly assigned to gradually discontinue the drugs, the others made no medication changes . Whether similar results would be found in other patients taking other antidepressants isn’t known.

While 56% of the patients who discontinued their medication relapsed during the study, Lewis emphasized that a sizeable portion did not, including most who remained on their antidepressants.

“There are many people who would like to stay on their antidepressants and the paper shows that for many people that is an appropriate decision,’’ Lewis said.

Editorial author Dr. Jeffrey Jackson of Milwaukee’s Veterans Affairs Medical Center, called the study results important but disappointing. But he also suggested that discontinuing antidepressants is possible for some patients.

“I encourage patients with a single bout of depression, especially episodes that are triggered by a life event, such as loss of a loved one, to consider weaning antidepressant treatment after at least 6 months of remission,’’ Jackson wrote in the editorial.

___

Follow AP Medical Writer Lindsey Tanner at @LindseyTanner.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Connect with PIX11 Online

Connect with PIX11 Online

Trending Stories

Don't Miss